{"id":26116,"date":"2024-07-25T04:01:00","date_gmt":"2024-07-24T20:01:00","guid":{"rendered":"http:\/\/csccm.org.cn\/?p=26116"},"modified":"2024-07-26T04:55:37","modified_gmt":"2024-07-25T20:55:37","slug":"jama%e5%8f%91%e8%a1%a8%e8%ae%ba%e6%96%87%ef%bc%9a%e6%8d%90%e7%8c%ae%e8%82%be%e8%84%8f%e5%90%8e%e7%9a%84%e9%ab%98%e8%a1%80%e5%8e%8b%e5%92%8c%e8%82%be%e8%84%8f%e5%8a%9f%e8%83%bd","status":"publish","type":"post","link":"https:\/\/csccm.org.cn\/?p=26116","title":{"rendered":"[JAMA\u53d1\u8868\u8bba\u6587]\uff1a\u6350\u732e\u80be\u810f\u540e\u7684\u9ad8\u8840\u538b\u548c\u80be\u810f\u529f\u80fd"},"content":{"rendered":"\n<p>Original Investigation&nbsp;<\/p>\n\n\n\n<p>May&nbsp;23,&nbsp;2024<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Hypertension and Kidney Function After Living Kidney Donation<\/h1>\n\n\n\n<h3 class=\"wp-block-heading\">Amit X.&nbsp;Garg,&nbsp;Jennifer B.&nbsp;Arnold,&nbsp;Meaghan S.&nbsp;Cuerden,&nbsp;et al<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\"><em>JAMA.&nbsp;<\/em>Published online May 23, 2024. doi:10.1001\/jama.2024.8523<\/h3>\n\n\n\n<p>Key Points<\/p>\n\n\n\n<p><strong>Question<\/strong>&nbsp;&nbsp;Do normotensive living kidney donors, compared with nondonors, have a higher risk of hypertension in the first 7 years following donation?<\/p>\n\n\n\n<p><strong>Findings<\/strong>&nbsp;&nbsp;In this 17-center prospective cohort study that included 924 living kidney donors and 396 nondonors, there were no significant between-group differences in the risk of hypertension and no significant between-group differences in mean blood pressure or the change in blood pressure during a median follow-up of 7.3 years.<\/p>\n\n\n\n<p><strong>Meaning<\/strong>&nbsp;&nbsp;After accounting for differences in baseline risk, living donors had a similar risk of hypertension as nondonors in the 7 years following donation and no significant difference in mean blood pressure.<a><\/a><\/p>\n\n\n\n<p>Abstract<\/p>\n\n\n\n<p><strong>Importance<\/strong>&nbsp;&nbsp;Recent guidelines call for better evidence on health outcomes after living kidney donation.<\/p>\n\n\n\n<p><strong>Objective<\/strong>&nbsp;&nbsp;To determine the risk of hypertension in normotensive adults who donated a kidney compared with nondonors of similar baseline health. Their rates of estimated glomerular filtration rate (eGFR) decline and risk of albuminuria were also compared.<\/p>\n\n\n\n<p><strong>Design, Setting, and Participants<\/strong>&nbsp;&nbsp;Prospective cohort study of 924 standard-criteria living kidney donors enrolled before surgery and a concurrent sample of 396 nondonors. Recruitment occurred from 2004 to 2014 from 17 transplant centers (12 in Canada and 5 in Australia); follow-up occurred until November 2021. Donors and nondonors had the same annual schedule of follow-up assessments. Inverse probability of treatment weighting on a propensity score was used to balance donors and nondonors on baseline characteristics.<\/p>\n\n\n\n<p><strong>Exposure<\/strong>&nbsp;&nbsp;Living kidney donation.<\/p>\n\n\n\n<p><strong>Main Outcomes and Measures<\/strong>&nbsp;&nbsp;Hypertension (systolic blood pressure [SBP] \u2265140 mm Hg, diastolic blood pressure [DBP] \u226590 mm Hg, or antihypertensive medication), annualized change in eGFR (starting 12 months after donation\/simulated donation date in nondonors), and albuminuria (albumin to creatinine ratio \u22653 mg\/mmol [\u226530 mg\/g]).<\/p>\n\n\n\n<p><strong>Results<\/strong>\u00a0\u00a0Among the 924 donors, 66% were female; they had a mean age of 47 years and a mean eGFR of 100 mL\/min\/1.73 m<sup>2<\/sup>. Donors were more likely than nondonors to have a family history of kidney failure (464\/922 [50%] vs 89\/394 [23%], respectively). After statistical weighting, the sample of nondonors increased to 928 and baseline characteristics were similar between the 2 groups. During a median follow-up of 7.3 years (IQR, 6.0-9.0), in weighted analysis, hypertension occurred in 161 of 924 donors (17%) and 158 of 928 nondonors (17%) (weighted hazard ratio, 1.11 [95% CI, 0.75-1.66]). The longitudinal change in mean blood pressure was similar in donors and nondonors. After the initial drop in donors\u2019 eGFR after nephrectomy (mean, 32 mL\/min\/1.73 m<sup>2<\/sup>), donors had a 1.4-mL\/min\/1.73 m<sup>2<\/sup>\u00a0(95% CI, 1.2-1.5) per year lesser decline in eGFR than nondonors. However, more donors than nondonors had an eGFR between 30 and 60 mL\/min\/1.73 m<sup>2<\/sup>\u00a0at least once in follow-up (438\/924 [47%] vs 49\/928 [5%]). Albuminuria occurred in 132 of 905 donors (15%) and 95 of 904 nondonors (11%) (weighted hazard ratio, 1.46 [95% CI, 0.97-2.21]); the weighted between-group difference in the albumin to creatinine ratio was 1.02 (95% CI, 0.88-1.19).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939414\/joi240062f1_1721328829.26144.png?Expires=1724788646&amp;Signature=h04DF1stkfFIeD3EDqfLaZ4N9THbJQEAzIwD7EBEpzgru~-JnnmTFToT0eArBEadT6Uxrkzs5OmFRlo8ks7a3KdqFnv1WW4XEGIZfiEc~455ecKTlz-H4dV9Cp0B0tDCknqQ~qd408eL1yq-N5mlRHApXoP1F2hbGJCFINUb20xmzGTVIXgwdXpw-XasJQ~6Xc6XF~QOSoIkz-kh1bLA67GB0Rq~MDD5S5BuXuHscPH-qNQmE0uHBvAaJ7AacFs0q3rNtKhHPjijroIOHKojbAOZw2in3gZyMlhgCvtLPWLexGLeeLKC--4b3ujfamxBHvXwc4wtcZaBIiJPlFqjjw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939414\/joi240062f2_1721328829.29644.png?Expires=1724788646&amp;Signature=xIP12tOJ1emvYrba9LpGO3qJtkHqAQZFvOfJBmSskanU9-Seu8h-IUP8hzGWHfbKNL63XKE0MwFob~2pa4SUd30k5ebMyf9RrtBEfJY82RLdO7tjtTI~KuY7-SuH9wdbCkj5GIoMcmLN~HnQL2sLPk8J-TeT~rtupUXss2BbgS45DTdIZFeun8HGq6T0cSSwatYzUuTw~JYHaOWQrFsx2wyBTrudfmfJWvfQhJ6LnVgpRsEE4FEmMMQ~L~gFYEWqKs~-xytStENOl~LhqbasG9vyPyywEsh9pQQO1Cc9ELDmQZJmePVvfQ1pT-I5mawpGWnO6~bXmPeF5y-DjW3IQg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939414\/joi240062f3_1721328829.30644.png?Expires=1724788646&amp;Signature=iR6kZmpPAiWj0amY4VtAw4Tw12q1CSWhqJr4f7Kddf~28Ncd1TJKL1kBak222Yrhzu7y-JH-x-ys7U1fu-s-MOu8PL2VyXYGZ5VOslbIh0be3f1xJJCW8CGBCYhUFGwiSplhvr9sRUxG~MyjGJc~q6rFK1qHIEzMJ5r2g73qjsC~OCZ2c9HyhotH6xj9Qug-VGtJ7ceY3MXUTdnLBL2Vtgxz0rhk8Zun9kJNkLco~bPEwVNE7lzDAFjYynk5HvYZfaRBfkGWYxOYFeyUujXt5cushFCGcto6HvfyxcqZe6DI9ATzkIYgFqBw4ZcEg18BXYSepkiQuIBoXPj1Bht7qA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939414\/joi240062t1_1721328829.18621.png?Expires=1724788646&amp;Signature=RB0-TgF10SxBi1R3lJzkrc9iUNSkL0a6CIev-ACd5iqgrRT~4ekmdvmwVLgx6wRglQpipNa4QzEE5eOO9TcupyWTbIHoGEkTW-7Mk5k-WyQgOVhlS5JJ6xgyJkELyhtVLmBSnLZyWsU6yKaDRnkr~JZYv5mEsgFeVJJEc5ie~9eAuCZhKr8sFoWbvP9yQ7Uy~vdu62uam68uSHhoOljwSmaTsveYPeGTHKP3ZDen~KOHtPz6BaEw86xeDA7LadGvfh5nR0-i-Q2pgcfHeSr1vPN3hXHs~4h9RjKMm7z91mFRdL-JTEB~~xiS5vpDTznTESZlB~v8H1bsq7W6wdqvrQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939414\/joi240062t2_1721328829.28144.png?Expires=1724788646&amp;Signature=di0VufDheVZnSqVhtDqNKfpHw9rqf3tmd9ZO1Tj6j38Kp6S~OabYuBIbnvE58ZIfpnBG0yp071N6UWC4THSlICdXhFzvM4nds2GkDJih1zZtWv6WANM~d5qRUi03oZ27eVU733w3Tn1YTI6VijCASX4LjHeGZ3SKmpeHeLCT3V-IALdtmN2xlQmW7~vFEtYS3CXiNWmzKWQPWYzxSiRws89EWPdRPeDzMldm9yeK04Ew9sS15dbUWcI02rsAwa-hWp~wJDigZ-a3SAUFKAbEyvnWlR~OhsNS8ql~wAXTEbEIOaWsxk1jX4cFK4StfVs2qonZeSBIx4lUwpYm9EzukQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<p><strong>Conclusions and Relevance<\/strong>&nbsp;&nbsp;In this cohort study of living kidney donors and nondonors with the same follow-up schedule, the risks of hypertension and albuminuria were not significantly different. After the initial drop in eGFR from nephrectomy, donors had a slower mean rate of eGFR decline than nondonors but were more likely to have an eGFR between 30 and 60 mL\/min\/1.73 m<sup>2<\/sup>&nbsp;at least once in follow-up.<\/p>\n\n\n\n<p><strong>Trial Registration<\/strong>&nbsp;&nbsp;ClinicalTrials.gov Identifier:&nbsp;<a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00936078\">NCT00936078<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Original Investigation&nbsp; May&nbsp;23,&nbsp;2024 Hyp [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[32,23],"tags":[],"_links":{"self":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/26116"}],"collection":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26116"}],"version-history":[{"count":2,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/26116\/revisions"}],"predecessor-version":[{"id":26460,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/26116\/revisions\/26460"}],"wp:attachment":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}